Headquartered in Hyderabad, India, Granules offers collaborative and strategic partnership to global pharmaceutical leaders by producing best quality API, PFI and FD through manufacturing …

We strive to provide access to safe, effective and affordable medicines to the people who need them. Here is how our key strengths help us achieve our objective.

Corporate Office Address: 15th Floor, Granules Tower, Botanical Garden Road, Kondapur, Hyderabad – 500084, Telangana, India. CIN: L24110TG1991PLC012471 Telephone: +91 40 69043500 Fax: +91 …

This acquisition strengthens Granules’ portfolio and opens up growth opportunities in the integrated Generics space in coming years. Granules will provide finished dosages of the new APIs in order to …

This achievement highlights Granules’ expanding capabilities in complex formulation development and regulatory execution. It reinforces the Company’s ability to identify, develop, and progress technically …

Our Gagillapur unit is one of the largest single unit manufacturing site for PFIs and Finished Dosages which we are further adding to by increasing technology based capacities. In an effort towards …

Granules India is leading by example, embedding sustainability across operations—from pioneering green molecules through CZRO to tackling Scope 3 emissions and accelerating renewable energy …

Granules in the news Featured in this section are important public updates pertaining to our products, performance and business, along with print coverage in the media.

Granules US is led by a team of seasoned professionals of the pharmaceutical industry. Each leader brings in-depth expertise and a modern outlook to tackle the challenges of today’s dynamic business.

Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India. We manufacture high-quality API, FD, PFI and Speciality Products with a …